Sensorion granted rare pediatric disease designation by FDA for lead therapy gene
Sensorion has announced that the US Food and Drug Administration (FDA) has granted rare pediatric…
November 7, 2022 - 2 minutes
hearing loss
Sensorion gets go-ahead from France for trial of drug to prevent hearing loss
Biotech company, Sensorion, today (October 24) announced that the initiation of a proof of concept…
October 24, 2022 - 3 minutes
Sensorion receives positive opinion from EMA for treatment of hearing loss
The European Medicines Agency (EMA) through its Committee for Orphan Medicinal Products (COMP) has adopted…
September 12, 2022 - 3 minutes
Beyond Biotech podcast 6: Mogrify, +ND Capital, Poolbeg Pharma
On this week’s podcast, our guests are Jeremy Skillington, CEO of Poolbeg Pharma; Dani Bach,…
July 22, 2022 - 7 minutes
Mogrify and Astellas to address sensorineural hearing loss
Biopharma company Mogrify Limited, and Japanese regenerative medicine firm Astellas Pharma Inc., have announced a…
July 5, 2022 - 2 minutes
Progress for hearing preservation trial after Australian approval granted
Approval has been granted by the Australian authorities to allow a French company to progress…
July 1, 2022 - 3 minutes
